In this perspective, we examine the available experimental and clinical evidence of the involvement of these molecules in two major neurodegenerative diseases, Alzheimer’s disease (AD) and multiple sclerosis (MS), and propose a more global picture of the pathogenic and pathological role of the IL-1/IL-1R system. This evidence concerns the gene IL1B and early-onset autosomal dominant Alzheimer disease.